FDA Announces New Pradaxa Study Results – Jackson Allen & Williams, LLP Takes Pradaxa Cases

An FDA study found that the risk of gastrointestinal (GI) bleeding is higher with the use of the drug Pradaxa than it is with the use of warfarin. Jackson Allen & Williams represents individuals who suffered health complications after taking Pradaxa. Dallas, TX (PRWEB) May 16, 2014 The U.S. Food and Drug Administration (FDA) had just released the results of a new study that compared the risk levels of certain serious health complication in two blood thinner drugs—Pradaxa and warfarin. The FDA made the announcement in a Drug Safety Communication* that was posted on the federal agency’s
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories